//
AIM2-driven inflammasome activation in heart failure
Natriuretic Peptide-Guided Heart Failure Therapy After the GUIDE-IT Study
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE